Kangmei Pharmaceutical to host Q3 2025 earnings briefing

Kangmei Pharmaceutical Co., Ltd. will host its 2025 third-quarter earnings briefing on Friday, November 21, 2025, from 15:00 to 16:00. The event will be held via network interaction on the Shanghai Stock Exchange Roadshow Center, following the release of the company's Q3 2025 report on October 31, 2025. This briefing aims to provide investors with a comprehensive understanding of Kangmei Pharmaceutical's operating results and financial condition.

Investors can submit questions in advance from Friday, November 14, 2025, to Thursday, November 20, 2025, at 16:00. Questions can be submitted through the "Question Pre-collection" section on the roadshow center website (https://roadshow.sseinfo.com/) or by emailing kangmei@kangmei.com.cn. The company plans to address commonly asked questions during the briefing. Key participants will include chairman Lai Zhijian, general manager Ou Guoxiong, board secretary Zhou Yunfeng, independent director Luo Tao, and cfo Gong Guiyang.

For further inquiries, investors may contact the company's Securities Affairs Department at 0755-33187777 or via email at kangmei@kangmei.com.cn. A recording and summary of the briefing will be available on the Shanghai Stock Exchange Roadshow Center after the event concludes.